Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion type Assertion NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_head.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion description "[Strong cMET[pY1003] membrane immunoreactivity was expressed in 6% of 149 tumors analyzed and was significantly associated with progressive disease (P = 0.019) and shorter TTP (P = 0.041).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_provenance.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion evidence source_evidence_literature NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_provenance.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion SIO_000772 18467317 NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_provenance.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion wasDerivedFrom befree-20140225 NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_provenance.
- NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_assertion wasGeneratedBy ECO_0000203 NP761672.RARgNW4XlFtJ0Sip9npYWxMlmGTQ2VswapEC95dfSyJiA130_provenance.